AI's Inflection Point: Bridging the Adoption and ROI Gap

Artificial intelligence in the life sciences industry is rapidly moving beyond experimentation toward scalable, outcome-driven innovation. But in which pursuits is it delivering — or should be delivering — the most value today? In this Pharmaceutical Executive Academy forum broadcast, co-hosted by Pharm Exec and Young & Partners, moderator Peter Young and Najat Khan, PhD, CEO and president of Recursion Pharmaceuticals, explore, from R&D through manufacturing, what’s working and where expectations may be outpacing results.

At a time when AI dominates headlines, the candid discussion, where Khan also shares the inspiring story behind her career path, offers an important reminder: the real measure of the technology will ultimately be better medicines and better patient outcomes.